Delivery Order SPE2DB24D9144-SPE2DB25FCMQM
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,677.18 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Menquadfi vials (0.5mL). This firm fixed-price delivery order is expected to be completed by September 3, 2025, with performance taking place at the contractor's Park Ridge facility. No set-aside designation was utilized in this award. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,677.18 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Menquadfi vial 0.5ML. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, and was executed on October 29, 2025. No set-aside designation was utilized for this award. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,338.59 contract is for the delivery of MENQUADFI VIAL 0.5ML medication, with a period of performance through November 2024. DMS Pharmaceutical Group holds a large single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and valid...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a Delivery Order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $3,897.65, is for the supply of the pharmaceutical product "MENQUADFI VIAL 0.5ML" to support the medical needs of military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $37,832.55 firm fixed-price purchase order by the Department of Defense's Medical Supply Chain on August 10, 2025, with an ultimate completion date of August 25, 2025. The contract is designated as a Total Small Business set-aside and covers the supply of Meningococcal Group vaccines and related pharmaceutical products to support federal healthcare operations. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price purchase order valued at $41,795.96 by the Defense Logistics Agency's Medical Supply Chain division on July 21, 2025. The contract, designated as a Total Small Business set-aside, covers the supply of meningococcal group vaccines and related pharmaceutical products. The award was issued rapidly following a solicitation posted on July 15, 2025, with a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $2,338.59, is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. The order has a completion date of May 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,522.17 for MENVEO Vaccine VL 5S under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program. The award is firm fixed price with no set-aside designation, and the ultimate completion date is July 31, 2025. This delivery order represents one of numerous pharmaceutical product orders issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $4,947.96 firm fixed-price delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine. The contract, which carries an ultimate completion date of August 15, 2025, was issued without a set-aside designation. Performance will take place in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,628 contract is for the delivery of meningococcal group vaccines and medical supplies, with a period of performance through June 2025. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, allowing the agency to issue...
- SPE2DB24D9144Indefinite Delivery Contract
- SPE2DB24D9144-SPE2DB25FCMQMDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,338.59 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Menquadfi vial 0.5ml. The contract is a firm fixed-price delivery order with an ultimate completion date of April 25, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance with the DLA. The company specializes in distributing branded and generic prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare sites nationwide. This delivery order for Menquadfi, a meningococcal vaccine, exemplifies the company's ongoing role in supporting military medical readiness and personnel health protection. The firm's status as a woman-owned small business and its established presence in federal procurement markets since 2001 have enabled it to compete effectively and maintain a robust portfolio of pharmaceutical product deliveries to government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/24/25 |